Cargando…
Human hepatocellular cancers show decreased prostaglandin E1 binding capacity.
Specific binding of 3H-PGE1 to plasma membranes prepared from normal human hepatic tissue in the presence of Mg2+ reached saturation at concentrations greater than 50 nM, and could be displaced in the rank-order PGE1 greater than PGE2 greater than PGI2 greater than PGD2 greater than PGF2 alpha at 4...
Autores principales: | Virgolini, I., Sinzinger, H., Müller, C., Hermann, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247058/ https://www.ncbi.nlm.nih.gov/pubmed/2539179 |
Ejemplares similares
-
Decrease of prostaglandin I2 binding sites in thyroid cancer.
por: Virgolini, I., et al.
Publicado: (1988) -
Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
por: Virgolini, I., et al.
Publicado: (1990) -
Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.
por: Li, S. R., et al.
Publicado: (1993) -
Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E(2) synthesis in vitro and ameliorates experimental periodontitis in vivo
por: Kats, Anna, et al.
Publicado: (2013) -
Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.
por: Virgolini, I., et al.
Publicado: (1993)